Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Management of Supratentorial Pleomorphic Xanthoastrocytomas in Children

This page was last updated on May 9th, 2017

Initial Management at Presentation

  • Control of seizures
  • Surgical resection: Total resection is the treatment of choice (16).

Adjunctive Therapies

  • Chemotherapy limited: Chemotherapy is usually considered ineffective for localized tumors (13, 25) but has been tried as a presurgical treatment to decrease blood loss (24). It has also been used in cases with leptomeningeal dissemination (28).
  • Radiation for anaplasia: Radiation therapy has a role only in PXAs with anaplastic features or in recurrent PXAs.


  • Scheduled follow-up: Typically, follow-up is planned for 4–6 weeks after surgery.
  • Postoperative imaging important: The first postoperative imaging should be done within 72 hours to make sure there is no residual tumor or to assess its size if tumor remains. Follow-up imaging will then depend on the pathology of the tumor (anaplastic or not). Typically, classical PXAs would be followed every year for the first 10 years, then every 2–3 years after that.

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.